These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20691983)

  • 81. RNA-sequencing identifies novel transcriptomic signatures in intestinal failure-associated liver disease.
    Jiang L; Wang N; Cheng S; Liu Y; Chen S; Wang Y; Cai W
    J Pediatr Surg; 2022 Sep; 57(9):158-165. PubMed ID: 35033352
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Effects of total parenteral nutrition containing essential trace elements on their concentrations in rats].
    Matsuda A; Kimura M; Yokoi K; Kabata H; Itokawa Y; Kataoka M; Sato M
    Nihon Eiseigaku Zasshi; 1989 Feb; 43(6):1140-8. PubMed ID: 2501545
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatocyte growth factor-mediated apoptosis mechanisms of cytotoxic CD8
    Chen Q; Yan M; Lin H; Lai J; Yang Z; Hu D; Deng Y; Shi S; Shuai L; Zhang L; Zhang H; Bai L
    Cell Death Discov; 2023 Jan; 9(1):13. PubMed ID: 36658107
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Chronic liver diseases: what physicians and patients hope for. New strategies against liver cell death].
    Vetter C
    MMW Fortschr Med; 2003 Jun; 145(26):10. PubMed ID: 12916330
    [No Abstract]   [Full Text] [Related]  

  • 85. TPN-induced sympathetic activation is related to diet, bacterial translocation, and an intravenous line.
    Sax HC
    JPEN J Parenter Enteral Nutr; 1995; 19(5):419-20. PubMed ID: 8577024
    [No Abstract]   [Full Text] [Related]  

  • 86. Determine whether 1 week of total parenteral nutrition (TPN) in healthy subjects alters systemic responses to a subsequent dose of endotoxin.
    Lowry SF; Fong Y
    Ann Surg; 1996 Jan; 223(1):107-8. PubMed ID: 8554412
    [No Abstract]   [Full Text] [Related]  

  • 87. Potential mechanisms underlying the effect of hepatocyte growth factor on liver injury in short bowel syndrome model rats.
    Sugita K; Yano K; Matsukubo M; Iwamoto Y; Ogata M; Takada L; Kedoin C; Murakami M; Harumatsu T; Onishi S; Kawano T; Muto M; Kumagai K; Ido A; Kaji T; Ieiri S
    Pediatr Surg Int; 2023 Nov; 40(1):8. PubMed ID: 37999791
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Autoserum: An Optimal Supplement for Bone Marrow Mesenchymal Stem Cells of Liver-Injured Rats.
    Zhang Q; Sun X; Ding J; He P; Liu Y; Cheng H; Zhou C; Meng X
    Stem Cells Int; 2015; 2015():459580. PubMed ID: 26089916
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Glycyrrhizin represses total parenteral nutrition-associated acute liver injury in rats by suppressing endoplasmic reticulum stress.
    Tsai JJ; Kuo HC; Lee KF; Tsai TH
    Int J Mol Sci; 2013 Jun; 14(6):12563-80. PubMed ID: 23771023
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Adenovirus-mediated dual gene expression of human interleukin-10 and hepatic growth factor exerts protective effect against CCl4-induced hepatocyte injury in rats.
    Qiu H; Yan Y; Xing J; Zhu Y; Fang L; Cao X; Su C
    Dig Dis Sci; 2012 Jul; 57(7):1857-65. PubMed ID: 22399249
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Therapeutic guidelines for subacute hepatic failure.
    Bhatia V; Sarin SK
    Indian J Gastroenterol; 1993 Dec; 12 Suppl 3():25-7. PubMed ID: 8005633
    [No Abstract]   [Full Text] [Related]  

  • 92. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury.
    Katz MS; Thatch KA; Schwartz MZ
    J Surg Res; 2010 Oct; 163(2):294-8. PubMed ID: 20691983
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
    Thatch KA; Katz MS; Haber MM; Schwartz MZ
    J Pediatr Surg; 2010 Jan; 45(1):89-94. PubMed ID: 20105586
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
    Thatch KA; Schwartz MZ; Yoo EY; Mendelson KG; Duke DS
    J Pediatr Surg; 2008 Dec; 43(12):2169-73. PubMed ID: 19040928
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
    García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
    Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.